November 18th, 2009
At the AHA: Intravenous Iron Therapy Improves Symptoms in Heart Failure
Larry Husten, PHD
In the FAIR-HF trial, NYHA II/III heart failure patients with LVEF ≤40 to 45% and iron deficiency benefited from intravenous iron with respect to symptoms, functional capacity, and quality of life but not survival. Dr. Fred Masoudi summarizes the findings. Editorialist Dr. William Dec weighs in.
